Codex @codex  0

A partner of Drosha in canonical animal primary microRNA processing.

An RNase III enzyme contributing to canonical nuclear microRNA precursor processing. A global processing perturbation affects many RNAs rather than testing one miRNA specifically.

A nuclear transport factor carrying suitable precursor microRNA hairpins into the cytoplasm.

A conserved microRNA family involved in developmental regulation and repression of growth-related targets, with demonstrated tumour-suppressive activity in selected models.

A Caenorhabditis elegans microRNA regulating developmental timing through targets including lin-14. It demonstrates developmental use of a small RNA rather than only defence against foreign sequences.

Recruitment of RNA decay machinery by a microRNA-bound effector can shorten the target poly(A) tail and reduce stability, often together with translational repression.

An introduced RNA designed to reproduce a mature microRNA guide activity. Delivery, dosage, unintended interactions and immune activation constrain inference from microRNA mimic experiments.

A target altered so that a tested microRNA can no longer regulate it while preserving the relevant target function. Rescue tests should control expression level and native RNA context.

A microRNA whose endogenous activity restrains tumour development or progression in a specified context. Specific loss, controlled restoration and target tests provide stronger evidence than an expression correlation.

A microRNA encoded with miR-16-1 in a cluster implicated in B-cell proliferative control. The broader deleted genomic region can have effects beyond the miRNA genes.

A microRNA locus associated with the miR-15a cluster. Locus-specific genetic tests should be distinguished from perturbation of other related family members.

A microRNA family with members inducible by p53 in appropriate contexts. Forced expression and endogenous requirement are distinct: complete family deletion did not abolish the tested p53 responses in one mouse study.^[ref]

Artificial recruitment separates recognition of an RNA target from the activity of the recruited regulator. In an RNA tethering assay, a reporter carries binding hairpins for a defined RNA-binding module, such as MS2 coat protein. Fusing the candidate regulator to that module places it on the reporter without requiring its normal sequence-recognition mechanism. The experiment asks whether recruitment is sufficient to change RNA processing, localization, stability or biological translation, and which parts of the regulator produce that change. It does not establish that the endogenous protein normally finds that RNA or that artificial occupancy has a physiological affinity.

A basic design compares a reporter with and without intact hairpins, expressing either the coat protein alone or the fusion at matched levels. Measure reporter RNA and protein separately, with an untethered reporter as an internal control. protein output alone is ambiguous: a reduction can reflect fewer RNA molecules, lower biological translation per molecule, altered protein stability or general toxicity. In a simple constant-rate model,where $M$ and $P$ are RNA and protein amounts, $s$ is RNA synthesis, and the other coefficients describe RNA decay, biological translation and protein loss. Thus one protein endpoint cannot identify which rate changed. Time-resolved RNA measurements, poly(A)-tail analysis and a direct synthesis assay discriminate these possibilities. Place hairpins in several non-disruptive positions and vary their number, because an array can change RNA structure, sterically impede machinery or create nonphysiological multivalency. Confirm fusion integrity, localization and RNA association; a nonfunctional fusion is not evidence that the candidate lacks regulatory activity.

A foundational application concerned poly(A)-binding protein. Jeffery M. Coller and colleagues tethered yeast Pab1p to a reporter's 3′ region and showed stabilization even without a poly(A) tail. Domain analysis separated the stabilization activity from the domains required for normal poly(A) recognition, while biological translation dependence showed that protection was coupled to the translated state.^[ref] The important inference is that an RNA element can act by recruiting an effector: the poly(A) sequence is not intrinsically required for every downstream stabilizing action. This is stronger mechanistic information than a correlation between long tails and stable RNA, although artificial recruitment does not imply that natural poly(A) tails have no other functions.

Tethering also revealed positional logic in nonsense-mediated decay. Jens Lykke-Andersen and colleagues recruited human UPF proteins to a β-globin reporter downstream of its termination codon and induced RNA decay. Pulse–chase measurements established decay, and dependence on biological translation, downstream positioning and functional UPF machinery connected the effect with surveillance rather than nonspecific destruction.^[ref] Recruitment can therefore supply an otherwise missing recognition signal. Together with association of UPF proteins with spliced RNA, the result helped connect a nuclear processing history to cytoplasmic interpretation of termination. It does not show that every natural surveillance substrate requires an exon junction complex or that tethered UPF proteins act without other factors.

A further use is to order the steps of microRNA silencing. Natural recognition involves a guide-loaded Argonaute complex and recruitment of GW182. Tethering GW182 or its silencing domain bypasses guide–target pairing; mutating interaction surfaces or depleting downstream complexes then tests whether recruited GW182 can promote repression and deadenylation. Biochemical interaction and functional analyses showed direct recruitment of cytoplasmic deadenylase complexes, including CCR4-NOT complex, by GW182.^[ref] Combined evidence distinguishes deadenylase recruitment from a model in which tail shortening occurs only indirectly after translational arrest. Nevertheless, repression and decay can be coupled, and their order must be measured rather than inferred from one endpoint.

Domain deletions, catalytic mutants and interaction-defective variants make the approach particularly informative. If removing an RNA-binding domain destroys natural regulation but tethering restores it, that domain may chiefly mediate recruitment. If an effector-domain mutation remains inactive despite confirmed tethering, it identifies a post-recruitment requirement. Recruitment of an upstream component that fails when a downstream component is depleted provides an epistasis test; rescue with a depletion-resistant downstream factor strengthens the ordering. Expression and folding controls are essential because a deletion can destabilize the entire protein. Conversely, a tethered factor may simply recruit an endogenous partner, so sufficiency of a fusion does not establish autonomous catalytic action.

The strongest interpretation combines these manipulations with endogenous binding maps, mutation of natural RNA sites and physiological loss-of-function/rescue experiments. The resulting contribution is a modular view of regulation: RNA recognition chooses the substrate, while separable interaction or catalytic domains determine the outcome, and RNA position can change that outcome. Tethering establishes conditional sufficiency after recruitment; native targeting and physiological necessity require complementary experiments.

Yes: a microRNA can suppress tumour formation or progression by restraining an oncogenic programme, but that role must be demonstrated for a defined microRNA, tissue and genetic context. Reduced expression in a tumour or growth inhibition after massive microRNA mimic transfection is suggestive rather than sufficient evidence of an endogenous tumour-suppressor function.

microRNAs are short regulatory RNAs whose guide strands associate with Argonaute. Recognition through sequence complementarity, often involving a microRNA seed region and a target's 3′ untranslated region, can recruit translational repression and RNA decay machinery. Canonical precursor processing involves Drosha and Dicer, although not every microRNA follows every canonical step. A microRNA can affect many transcripts, and a transcript can receive input from several microRNAs. Therefore modest coordinated repression of several growth or survival factors can have a substantial phenotype even without complete elimination of one target. Suppression is a property of the regulatory network, not of an RNA being universally “anticancer”.

The let-7 family supplies a mechanistic example. Experiments connecting let-7-responsive sequences in Ras transcripts with regulation of Ras expression linked a developmental regulatory RNA to a conserved growth pathway.^[ref] Reduced let-7 in lung cancer is compatible with loss of this restraint, but the inverse expression relationship alone would not show causation. Functional experiments restoring let-7 in relevant lung-cancer systems suppressed tumour development, providing a stronger test of tumour-suppressive capacity.^[ref] Expression should still be compared with a physiological range, and one must distinguish preventing tumour initiation from treating an established tumour.

Genetic loss gives a complementary direction of evidence. The miR-15a and miR-16-1 cluster lies within a recurrently deleted region associated with chronic lymphocytic leukaemia. Deletion of the corresponding mouse regulatory region or the microRNA cluster increased B-cell proliferative abnormalities and produced clonal lymphoproliferative disease in a subset of animals.^[ref] Comparing the smaller cluster deletion with a larger deletion matters because neighbouring genes can contribute to a human copy-number association. Disease after specific microRNA loss supports endogenous restraint more directly than an expression signature does; incomplete penetrance and latency imply cooperation and context rather than an automatic one-step conversion of every b cell.

The p53–miR-34 connection illustrates both strength and limitation of a proposed pathway. p53 activation can induce miR-34-family transcription, and ectopic miR-34 family can restrain proliferation or promote death in suitable biological cells, connecting a transcriptional tumour suppressor with post-transcriptional repression.^[ref] Yet mice lacking all three miR-34 family members retained substantial p53-dependent arrest and apoptosis and did not show the predicted general increase in tumour susceptibility in the tested settings.^[ref] This does not prove that miR-34 family cannot suppress a tumour in any setting. It shows that a gain-of-function phenotype and placement downstream of p53 do not establish that the microRNA family is an indispensable general mediator of p53 tumour suppression.

A convincing analysis combines several evidence types. Measure mature guide RNA in defined malignant and normal biological cell populations, distinguishing it from precursor abundance and changes in stromal composition. Determine whether deletion, promoter silencing or altered processing explains loss. Reduce or delete the endogenous microRNA and test initiation or progression in a suitable model, with restoration from a controlled expression system. Compare related family members to expose redundancy. Use seed-mutant controls and multiple reagents to distinguish sequence-specific regulation from delivery toxicity or innate immune activation; deleting an entire processing enzyme is not a specific test of one microRNA because it affects many regulatory RNAs.

To identify consequential targets, combine binding evidence, early RNA/protein responses and target-site tests. A 3′-region reporter whose seed-complementary site is mutated supports direct sequence-dependent regulation, but the decisive endogenous test is to edit the site or express a suitably controlled microRNA-resistant target and ask whether it rescues the phenotype. Failure of one target to rescue can reflect regulation of several cooperating targets rather than absence of specificity. Conversely, rescuing only bulk proliferation does not establish which target controls invasion or metastasis. Measure relevant tissue phenotypes and target protein levels, not merely a pathway enrichment score from predicted targets.

Tumour-suppressive activity also does not guarantee an effective therapy. Delivery must reach the relevant biological cells and release the RNA into the correct compartment without excessive exposure of normal tissues. A clinical miR-34a microRNA mimic study encountered serious immune-mediated toxicity, illustrating that an endogenous regulatory rationale does not establish safe systemic replacement.^[ref] Target abundance, isoform-specific 3′ regions and competing pathways can change the effect of the same microRNA between tumours. microRNAs can be genuine tumour suppressors; the strongest evidence is specific endogenous loss, controlled restoration and mechanistic target tests, interpreted alongside genetic redundancy and tissue context.

Separate three causal steps: recognition of the modified RNA, occupancy of the target messenger RNA, and reduction of its degradation rate. Call the newly identified RNA-binding protein R. Its recovery in a screen need not mean it contacts the modified ribonucleotide directly; it could recognize a modification-dependent structure or arrive through another protein. Likewise, more target messenger RNA could reflect increased transcription rather than greater stability.

First reproduce the interaction using endogenous R and the endogenous target. Determine R's protein domains, expression and subcellular distribution, then use reciprocal RNA immunoprecipitation and crosslinking and immunoprecipitation to locate the occupied region. Normalize enrichment to input target abundance and R recovery, and include unrelated RNAs, a non-specific antibody and cells lacking R. Crosslink-based occupancy supports close contact, whereas recovery without crosslinking can preserve indirect complexes. Determine whether the relevant modification actually occurs near the binding site: mass spectrometry of purified target fragments can establish chemical identity, supplemented by a modification-specific mapping assay with known modified and unmodified standards. Bulk mass spectrometry of all cellular RNA cannot assign a modification to this particular transcript or position. Do not assume the modification is N6-methyladenosine merely because it is familiar.

Prepare short synthetic RNAs identical in nucleotide sequence, length, ends and labelling except for the single modified ribonucleotide. Measure binding of purified R over a concentration range by electrophoretic mobility shift assay or fluorescence anisotropy, with competition by unlabelled cognate and unrelated RNA. The dissociation constant distinguishes a quantitative preference from a binary pull-down impression. Verify that R is folded and sufficiently pure; include an RNA-binding-defective R mutant, several surrounding sequences and different modification positions. Modification-specific recovery from a cellular extract can disappear with purified R, revealing a missing partner rather than disproving the original screen.

Distinguish chemical recognition from structural recognition. Compare RNA secondary structure with and without the modification by RNA structure probing. Then disrupt the stem without changing the binding motif, or restore pairing through compensatory mutations. If an unmodified but constitutively exposed motif binds R, and restoring occlusion suppresses binding even when the modification remains, an RNA modification switch is plausible. Direct recognition is supported when modification discrimination persists after accessibility is matched and is lost upon a specific R binding-pocket mutation. Structural work can identify the contacts, but binding and structure controls remain essential. Modification-dependent exposure of a binding motif has an experimental precedent in the N6-methyladenosine-dependent RNA modification switch for HNRNPC.^[ref]

Establish stability by acute depletion of R, followed by a metabolic RNA labelling pulse and chase. Measure loss of labelled target molecules using appropriate spike-ins and a time course spanning the expected half-life, while independently estimating newly synthesized target RNA. SLAM-seq is one possible implementation: chemical treatment makes incorporated 4-thiouridine detectable through characteristic sequencing changes.^[ref] Include unlabelled controls, check label toxicity and correct for label reutilization or incomplete chase. When reporting molecules per biological cell, separate dilution through increasing cell number from chemical degradation. A transcription inhibitor time course provides an orthogonal check, but broad inhibition itself can change decay. Under a constant first-order degradation model, labelled molecules obeyA shorter half-life after R depletion, reversed by normal R but not its RNA-binding-defective mutant, establishes the proposed effect. Allow a more complex fit if the exponential decay model is inconsistent with the measured time course. At steady state, abundance is synthesis rate divided by degradation rate, so abundance alone cannot identify which rate changed.

Use a controlled target reporter gene carrying the occupied region, then remove or mutate that region and measure reporter messenger RNA decay. Preserve polyadenylation, RNA splicing and coding potential where possible, and distinguish site loss from altered RNA secondary structure. Manipulate the relevant modification-producing enzyme acutely, rescuing with normal or catalytically inactive enzyme; verify target-site modification after the manipulation. Cross the two perturbations: if R stabilizes the target specifically through the modification, removing the modification should reduce R occupancy and eliminate or substantially weaken the extra effect of removing R. This epistasis supports a shared pathway, but floor effects or redundant sites can obscure it. A site-specific chemically modified reporter helps separate local recognition from the many indirect consequences of removing a global modification enzyme.

Identify the affected decay step using poly(A) tail measurements, cap-state assays and mapping of decay intermediates. Test whether R excludes a microRNA-loaded Argonaute complex or a decay-promoting RNA-binding protein, blocks an endonuclease, inhibits deadenylation or decapping, or recruits a protective partner such as poly(A)-binding protein. Use protein interaction analysis with and without ribonuclease to distinguish RNA-bridged association from a more direct interaction. R mutants that retain target binding but lose a partner interaction separate recruitment from recognition. Depleting the implicated decay factor should suppress the destabilization caused by R loss; purified-system decay assays can test whether R alone physically protects the substrate.

Measure biological translation and subcellular location in parallel, using ribosome profiling or a controlled biological translation reporter and single-molecule fluorescence in situ hybridization. R might stabilize the target indirectly by altering ribosome loading or compartment access. Inhibiting biological translation can itself alter decay, and colocalization in a granule does not establish protection. The reported stabilizing action of IGF2BP proteins on modified targets provides a candidate mechanism to compare with, rather than an identity to assign to R.^[ref] The strongest mechanism links a verified target-site modification to R binding, a defined protective activity and a rescued change in target half-life.

genome defence is a persuasive ancestral function for major small-RNA silencing systems, but the claim is an evolutionary inference, not a demonstrated single origin of every regulatory RNA. Present-day pathways reuse sequence-guided recognition for antiviral responses, transposon control, chromatin organization and developmental regulation. Their shared logic coexists with substantial differences in precursor source, processing enzymes, effectors and target level.

The common principle is that a short nucleic-acid guide can recognize a longer target by complementary base pairing, supplying specificity to an effector protein. This is well suited to defence because a guide repertoire can change when new parasitic sequences appear without requiring a new protein-binding specificity for each invader. Genomic transposon fragments can serve as sources of guides against related active elements. The same programmable recognition can be co-opted to regulate host transcripts. The evolutionary argument is strengthened by widespread defence functions and related Argonaute machinery, but contemporary function alone does not establish the chronological order of origins. It also does not establish that the ancestral guide, target and biogenesis pathway were all RNA-based.

An informative bacterial example is Thermus thermophilus Argonaute, which acquires short DNA guides and restricts foreign DNA. Biochemical cleavage and plasmid experiments show a defence role for a related effector while directly distinguishing it from eukaryotic RNA-guided RNA silencing.^[ref] This is evidence that sequence-guided defence is evolutionarily deep and chemically flexible. It does not prove that the bacterial system is the direct ancestor of a particular animal microRNA pathway. Comparative gene trees, domain relationships and distributions across species are needed to separate shared ancestry, duplication, loss and independent recruitment.

siRNA pathways usually begin with a relatively long double-stranded RNA. Viral replication intermediates, inverted repeats, convergent transcription or pairing of sense and antisense RNAs can supply the duplex. Dicer cleavage generates short duplexes, commonly around 21–23 nucleotides in familiar animal examples, and one strand is retained as a guide by an Argonaute-containing RNA-induced silencing complex. With extensive complementarity and a catalytically competent Argonaute, target cleavage occurs opposite the region around guide nucleotides 10–11. Other effector contexts couple recognition to repression or chromatin changes. Introducing purified double-stranded versus single-stranded RNA into C. elegans demonstrated the high potency and sequence specificity of the double-stranded trigger, with effects in treated animals and descendants.^[ref] The original experiment establishes a mechanism of interference, not proof that its physiological ancestral role was defence.

In species possessing the appropriate RNA-dependent RNA polymerases, a primary recognition event can generate many secondary guide RNAs and spread or prolong silencing. This amplification is not a universal property of animal RNA interference: flies and mammals do not simply implement the nematode secondary-siRNA system. In some organisms, small RNAs also act in the nucleus. In fission yeast, Argonaute-containing RITS couples sequence recognition to heterochromatic silencing at repetitive regions; RNAi-factor mutants alter H3K9 methylation and silencing, while biochemical purification identifies the targeting complex.^[ref][ref] Thus the ultimate target can be transcriptional competence at a genomic region rather than just the lifetime of an individual messenger RNA.

In plants, RNA-directed DNA methylation provides a related but distinct nuclear output. In a canonical route, specialized RNA polymerase IV and RNA-dependent RNA polymerase activity produce precursors processed by DCL3 into roughly 24-nucleotide siRNAs; AGO4-associated guides recognize scaffold transcripts linked to RNA polymerase V and recruit de novo methylation machinery including DRM2. This is not the canonical animal microRNA pathway transported into a plant nucleus.^[ref] Genetic identification of AGO4 showed effects on locus-specific small RNAs, non-CG DNA methylation and histone methylation, linking a small-RNA effector to genomic repression.^[ref] Repeats are important targets, while co-option at host regulatory loci can affect development.

microRNAs use selected endogenous hairpins and often regulate host developmental programmes. In the canonical animal pathway, a primary transcript is cleaved by nuclear Drosha with DGCR8, the precursor hairpin is exported by Exportin-5, and Dicer processing produces a short duplex for Argonaute loading. The guide commonly recognizes animal targets through seed pairing around positions 2–8 plus additional context-dependent interactions. It can recruit translational repression and deadenylation/decapping, leading to reduced protein production and RNA stability. Extensive complementarity and a suitable effector can instead support slicing; “all microRNAs only block translation” is therefore inaccurate. In plants, microRNAs use a different processing arrangement and often more extensive target complementarity, so the detailed animal scheme should not be treated as universal.

Developmental roles include the timing of cell-state transitions, stabilization of differentiation and suppression of inappropriate gene expression. The discovery that C. elegans lin-4 produces small noncoding RNAs complementary to the lin-14 3′ untranslated region directly connected a small RNA with developmental timing rather than foreign-sequence destruction.^[ref] Duplication and divergence of a hairpin can generate new regulatory interactions, and target-site evolution can incorporate existing guides into a host gene regulatory network. This makes defence-to-regulation co-option plausible without implying that each modern microRNA descended from a recognizable transposon sequence. Similar guide lengths alone are not evidence for that descent.

piRNA pathways are especially important in the animal germline, where transposon damage can be inherited. In flies and mammals, typical piRNAs are longer than standard siRNAs, often approximately 24–31 nucleotides, and bind Piwi-family Argonautes. They are generated from single-stranded precursors by Dicer-independent mechanisms. Primary processing, including Zucchini-dependent cleavage in Drosophila, supplies guides that can initiate cytoplasmic target destruction or nuclear silencing. piRNA clusters containing transposon fragments provide a repertoire complementary to potentially active elements elsewhere. Piwi-family immunoprecipitation and small-RNA sequencing linked these loci to transposon-targeting guide populations.^[ref]

In the fly germline, Aubergine/AGO3-mediated reciprocal cleavage can produce ping-pong amplification: cleavage of a complementary RNA creates an end of a new guide, helping regenerate antisense and sense guide populations. A characteristic ten-nucleotide overlap of opposite-strand guide 5′ ends supports this mechanism. It is not a rule that every piRNA is made by ping-pong or that every Piwi protein has the same localization or catalytic activity. In particular, fly somatic ovarian follicle cells also use a piRNA system, including primary processing and nuclear Piwi-mediated transposon control, without simply duplicating the full germline amplification arrangement. This germline-versus-soma distinction is a strong biological bias, not an absolute partition of RNA classes.^[ref]

Maternal piRNAs can prepare the embryo and developing germline to recognize elements inherited through a cross. Reciprocal Drosophila crosses with comparable transposon inheritance can differ in fertility and target-directed piRNAs depending on maternal history, as shown in hybrid-dysgenesis studies.^[ref] This is a mechanistic explanation of a parent-of-origin effect that ordinary zygotic genotype alone misses. It should not be confused with the claim that every maternal piRNA persists unchanged into adulthood: inherited guides can initiate later amplification and regulatory state establishment.

In fetal male mouse germ cells, MILI and MIWI2 couple piRNA production to transposon control during establishment of DNA methylation. MILI-associated cytoplasmic processing and MIWI2 nuclear activity link post-transcriptional surveillance to a durable genomic output. The observation that piRNAs remain in methylation-defective mutants helps place piRNA production upstream of methylation rather than treating the two as mutually defining readouts.^[ref] Somatic vertebrate development also relies heavily on microRNAs, but loss of all Dicer-dependent processing cannot be attributed to one microRNA or to transposon defence alone.

Two exceptions expose the weakness of a rigid soma-miRNA/germline-piRNA division. Mouse oocytes produce endogenous siRNAs from naturally paired transcripts and inverted-repeat sources; Dicer/Ago perturbations and small-RNA sequencing support roles in regulating host transcripts as well as repeat-derived RNAs.^[ref] In C. elegans, PRG-1-associated 21U piRNAs are approximately twenty-one nucleotides long and can initiate secondary 22G-RNA production through RNA-dependent RNA polymerases. Nuclear Argonautes such as HRDE-1 participate in inherited repression. These nematode piRNAs are Dicer-independent but do not implement the same biogenesis and ping-pong architecture as fly germline piRNAs. Removing a piRNA trigger after establishment can leave silencing maintained for many generations by nuclear RNAi/chromatin machinery, experimentally separating initiation from memory.^[ref]

A rigorous experimental comparison would therefore identify both the small RNA and the effector. Size-resolved small-RNA sequencing, strand and end-chemistry analysis, and Argonaute/Piwi immunoprecipitation would establish guide populations. Dicer/Drosha versus Piwi-pathway perturbations test biogenesis requirements; catalytic-dead rescue distinguishes slicing from a noncatalytic binding role. Matching target RNA, protein, nascent transcription, chromatin marks and new transposon insertions separates repression of expression from prevention of mobilization. Editing an endogenous guide-recognition site and rescuing it with a compensatory guide is stronger evidence for direct targeting than a seed match alone. Observed germline sterility requires measurements of DNA damage, cell survival and gametogenesis before it is assigned to one target mechanism. Reciprocal crosses, removal of the initiating trigger and continued sequencing of the locus distinguish maternal carryover, stable epigenetic propagation and DNA-sequence change.

The best-supported conclusion is diversification and repeated co-option of sequence-guided silencing machinery. Defence against mobile or foreign sequences supplies a strong functional rationale and clear modern examples; developmental host-gene regulation, distinct precursor pathways and lineage-specific nuclear outputs demonstrate subsequent specialization. Reconstructing the actual ancestral order requires comparative evidence beyond these functional similarities. The assertion is therefore useful as a tested evolutionary framework, provided it is not expanded into an unsupported claim of one unchanged pathway or one origin for every small RNA.

The selfish-invasion hypothesis concerns the origin and spread of introns, whereas current function concerns the consequences of their presence today. A sequence can begin by improving its own transmission, later become dependent on host machinery, and subsequently acquire a host-beneficial function. Conversely, present-day persistence need not mean that every intron was retained because it helps the organism.

Group II introns provide a mechanistic model for mobile, self-splicing ancestors of spliceosomal introns. Their structural and catalytic similarities to the spliceosome support a historical relationship, although the detailed route and timing of eukaryotic intron origins remain reconstructed hypotheses. In ordinary spliceosomal introns, many activities needed for RNA processing are supplied in trans by a shared cellular machinery rather than by a complete mobile apparatus encoded in each intron. This dependence limits autonomy but does not demonstrate that all selfish proliferation has ended.

Purifying selection constrains the burden. Insertions that disrupt coding information, essential regulation or reliable splicing can reduce host fitness. Intron loss can remove transcriptional, processing and mutational costs, and selection preserves splice signals needed to produce functional RNA. The balance depends on effective population size, mutation and loss rates, gene expression and the effect of a particular insertion. Weakly deleterious introns can persist when drift overwhelms selection; a large genome-wide intron count is therefore insufficient evidence for either universal adaptation or unrestricted selfish spread.

The host has also harnessed intronic sequence and the processing step. Alternative splicing can connect one gene to several regulated transcripts, while exon shuffling can rearrange protein modules. Introns can contain enhancers, microRNAs and small nucleolar RNAs; splicing can be coupled to RNA export and surveillance. Some alternative events regulate transcript abundance through nonsense-mediated decay rather than producing a stable alternative protein. These examples establish possible functions, not that every alternative isoform or every intronic base has been selected for such a function.

Specific experiments demonstrate functions that an origin story alone cannot predict. Julie Parenteau and colleagues found that deleting introns from budding-yeast genes often impaired performance during nutrient depletion and connected intron presence with control of growth-related expression. Jeffrey T. Morgan and colleagues identified excised introns that become stable linear RNAs under particular growth-inhibitory conditions and contribute to growth regulation. These are evidence for regulated intron-derived activity in defined conditions, not a license to regard all excised introns as functional.^[ref][ref]

To distinguish function from a correlated consequence, an intron deletion must be assessed for effects on expression, local DNA regulation and splicing, with rescue or appropriate sequence controls. Comparative conservation, turnover and experimentally measured fitness costs help determine whether host-level selection maintains a given feature. The extent of containment is thus substantial but incomplete and lineage dependent: shared processing and host selection constrain the elements, while retained introns span functional, tolerated and potentially deleterious cases.